LunaPBC

LunaPBC, Genetic Alliance create drug discovery platform for rare epilepsy

Health data platform LunaPBC and the Genetical Alliance partnered with the KCNT1 Foundation to launch a drug discovery program for KCNT-1 Epilepsy. The group will partner with Biogen to study the cause of the disease and develop treatments.

By Elise Reuter

LunaPBC is trading company shares for member health data

On the company's LunaDNA platform, a whole genome can be exchanged for 300 company shares, while 20 days of fitness data is equal to two shares.

By Kevin Truong

With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?

Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.